Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Istradefylline in Parkinson's Disease
NCT00957203Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Oct 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Istradefylline in Parkinson's disease (PD), sponsored by Kyowa Kirin. Started Oct 2009; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00957203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957203.